Absence of 5-HT3 and cholinergic mechanisms in improgan antinociception

Pharmacology Biochemistry and Behavior

Volumn 80, Issue 3, 2005, Pages 505-510

  Nalwalk, J W ^a   Svokos, K ^a   Leurs, R ^b   Hough, L B ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

5 HT3 receptor; Acetylcholine; Analgesia; Histamine; Improgan; Muscarinic cholinergic receptor; Nicotinic cholinergic receptor; Pain; Serotonin

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; ANALGESIC AGENT; ATROPINE; IMPROGAN; MECAMYLAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; ONDANSETRON; SEROTONIN 3 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; UNCLASSIFIED DRUG; 1 CYANO 2 [2 [(4 IMIDAZOLYL)METHYL]ETHYL] 3 METHYLGUANIDINE; CHOLINERGIC RECEPTOR; CIMETIDINE; DRUG DERIVATIVE; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; HOT PLATE TEST; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TAIL FLICK TEST; THERMAL ANALYSIS; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; METHODOLOGY; PAIN ASSESSMENT; PHYSIOLOGY; REACTION TIME; SPRAGUE DAWLEY RAT;

ANALGESICS; ANIMALS; CIMETIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, CHOLINERGIC; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 14544299220     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.01.006     Document Type: Article

References (32)

1. A.W. Bannon, M.W. Decker, M.W. Holladay, P. Curzon, D. Donnelly-Roberts, and P.S. Puttfarcken Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors Science 279 1998 77 81
2. M.D. Bannoura, J.W. Nalwalk, Y. Tang, M. Carlile, R. Leurs, and W.M.P.B. Menge Absence of antinociceptive tolerance to improgan, a cimetidine analog, in rats Brain Res. 814 1998 218 221
3. 3 receptor antagonists on spinal serotonin-induced analgesia in rats Brain Res. 765 1997 267 272
4. A. Bartolini, C. Ghelardini, L. Fantetti, M. Malcangio, P. Malmberg-Aiello, and A. Giotti Role of muscarinic receptor subtypes in central antinociception Br. J. Pharmacol. 105 1992 77 82
5. R.S. Bitner, A.L. Nikkel, P. Curzon, D.L. Donnelly-Roberts, P.S. Puttfarcken, and M. Namovic Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat Brain Res. 871 2000 66 74
6. A receptors Life. Sci. 75 2004 2551 2558
7. L.A. Crane, and S.D. Glick Simple cannula for repeated intracerebral drug administration in rats Pharmacol. Biochem. Behav. 10 1979 799 800
8. F.E. D'Amour, and D.L. Smith A method for determining loss of pain sensation J. Pharmacol. Exp. Ther. 72 1941 74 79
9. A. Duttaroy, J. Gomeza, J.W. Gan, N. Siddiqui, A.S. Basile, and W.D. Harman Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice Mol. Pharmacol. 62 2002 1084 1093
10. N.B. Eddy, and D. Leimbach Synthetic analgesics: II dithienylbutenyl and dithienylbutylamines J. Pharmacol. Exp. Ther. 107 1953 385 393
11. Fields HL, Basbaum AI, Heinricher MM. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R. (Eds.). Textbook of pain. Edinburgh: Churchill Livingstone, in press.
12. K.M. Gao, D.O. Chen, J.R. Genzen, and P. Mason Activation of serotonergic neurons in the raphe magnus is not necessary for morphine analgesia J. Neurosci. 18 1998 1860 1868
13. L.B. Hough Genomics meets histamine receptors: new subtypes, new receptors Mol. Pharmacol. 59 2001 1 5
14. L.B. Hough, J.W. Nalwalk, W.G. Barnes, R. Leurs, W.M.P.B. Menge, H. Timmerman, and M. Wentland A third life for burimamide: discovery and characterization of a novel class of non-opioid analgesics derived from histamine antagonists S.D. Glick I.M. Maisonneuve New medications for drug abuse 2000 New York Acad. Sci. New York 25 40
15. L.B. Hough, J.W. Nalwalk, Y. Chen, A. Schuller, Y. Zhu, and J. Zhang Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice Brain Res. 880 2000 102 108
16. L.B. Hough, J.W. Nalwalk, W.G. Barnes, R. Leurs, W.M. Menge, and H. Timmerman A third legacy for burimamide: discovery and characterization of improgan and a new class of non-opioid analgesics derived from histamine antagonists T. Watanabe H. Timmerman K. Yanai Histamine research in the new millenium 2001 Elsevier Amsterdam 237 242
17. L.B. Hough, J.W. Nalwalk, W.M. Menge, R. Leurs, and H. Timmerman Significance of GABAergic systems in the action of improgan, a non-opioid analgesic Life Sci. 68 2001 2751 2757
18. L.B. Hough, J.W. Nalwalk, R. Stadel, H. Timmerman, R. Leurs, and B.C. Paria Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4- methyl-1H-p yrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors J. Pharmacol. Exp. Ther. 303 2002 314 322
19. E.T. Iwamoto Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus J. Pharmacol. Exp. Ther. 257 1991 120 133
20. E.T. Iwamoto, and L. Marion Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats J. Pharmacol. Exp. Ther. 269 1994 699 708
21. J.M. Kiefel, M.L. Cooper, and R.J. Bodnar Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia Brain Res. 597 1992 331 338
22. B.Y. Li, J.W. Nalwalk, L.A. Barker, P. Cumming, M.E. Parsons, and L.B. Hough Characterization of the antinociceptive properties of cimetidine and a structural analog J. Pharmacol. Exp. Ther. 276 1996 500 508
23. B.Y. Li, J.W. Nalwalk, J.M. Finkel, S.D. Glick, and L.B. Hough SKF92374, a cimetidine analog, produces mechanical and thermal antinociception in the absence of motor impairment Analgesia 3 1997 15 20
24. J.E. Macor, D. Gurley, T. Lanthorn, J. Loch, R.A. Mack, and G. Mullen The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist Bioorg. Med. Chem. Lett. 11 2001 319 321
25. L.M. Marubio, Mar M. Arroyo-Jimenez, M. Cordero-Erausquin, C. Lena, N. Le Novere, and D.A. de Kerchove Reduced antinociception in mice lacking neuronal nicotinic receptor subunits Nature 398 1999 805 810
26. J.I. Mobarakeh, J.W. Nalwalk, T. Watanabe, S. Sakurada, M. Hoffman, and R. Leurs Improgan antinociception does not require neuronal histamine or histamine receptors Brain Res. 974 2003 146 152
27. J.W. Nalwalk, K. Svokos, O. Taraschenko, R. Leurs, H. Timmerman, and L.B. Hough Activation of brain stem nuclei by improgan, a non-opioid analgesic Brain Res. 1021 2004 248 255
28. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1986 Academic Press Sydney
29. T.S. Rao, L.D. Correa, R.T. Reid, and G.K. Lloyd Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (NAChR) ligands in the rat tail-flick assay Neuropharmacology 35 1996 393 405
30. 2 adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic Brain Res. 921 2001 12 19
31. M.D. Swedberg, M.J. Sheardown, P. Sauerberg, P.H. Olesen, P.D. Suzdak, and K.T. Hansen Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic J. Pharmacol. Exp. Ther. 281 1997 876 883
32. K.P. Zeitz, N. Guy, A.B. Malmberg, S. Dirajlal, W.J. Martin, and L. Sun The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors J. Neurosci. 22 2002 1010 1019